Medical Device | October 06, 2021
Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
The transaction is anticipated to close in the first quarter of 2022
The transaction is anticipated to close in the first quarter of 2022
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Subscribe To Our Newsletter & Stay Updated
